—do our best.
I've been in great communication with Health Canada. It has asked me to find small biotechs in Canada that we can introduce to Health Canada, to find the best research possibilities. It's not a guessing game here. This is a science game. We have to find the best opportunities and back those best opportunities with funds. I think we've done a really good job here in Canada.
Again, it's going to be hard. When you look at the therapeutics—I'm jumping away from vaccines for a second—we've been looking at in regard to clinical trials, there have been many indications that some of our already licensed products might have effects with COVID-19, and we've gone through it. We've gone through many trials and lots of money.
Unfortunately, with all that we've done, we're not really seeing many candidates that are actually going to be helping us, and that's just the nature of the business. We have to innovate. We have to invest. We have to study, and then we're hoping we will find some help from therapeutics and vaccines.